Clinical Trials Directory

Trials / Completed

CompletedNCT01245933

Impact of Systemic Manifestations/Comorbidities on Clinical State, Prognosis, Utilisation of Health Care Resources in Patients With COPD

Impact of Systemic Manifestations/Comorbidities on Clinical State, Prognosis and Utilisation of Health Care Resources in Patients With COPD

Status
Completed
Phase
Study type
Observational
Enrollment
2,741 (actual)
Sponsor
Philipps University Marburg · Academic / Other
Sex
All
Age
40 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine the prevalence and severity of extrapulmonary disorders and to quantify the impact of extrapulmonary organ manifestations on morbidity and mortality of COPD patients. Furthermore the investigators evaluate the relationship between systemic inflammation and organ involvement.

Detailed description

Chronic diseases and comorbidities have an increasing impact on individual life and health care use, as exemplified in chronic obstructive pulmonary disease (COPD). Currently, independent, comprehensive databases allowing for an integrated view are lacking. The study will for the first time establish a large, comprehensive longitudinal database covering a broad panel of comorbidities an markers of systemic alterations. These data will be of unique value in revealing specific phenotypes of COPD via patterns and risk profiles of comorbidities, enabling a more precise diagnosis and targeting of therapy, and an efficient allocation of resources.

Conditions

Timeline

Start date
2010-11-01
Primary completion
2013-12-01
Completion
2023-12-01
First posted
2010-11-23
Last updated
2024-04-12

Locations

22 sites across 1 country: Germany

Source: ClinicalTrials.gov record NCT01245933. Inclusion in this directory is not an endorsement.